NASDAQ:RIGL - Nasdaq - US7665597024 - Common Stock - Currency: USD
Taking everything into account, RIGL scores 6 out of 10 in our fundamental rating. RIGL was compared to 566 industry peers in the Biotechnology industry. RIGL has only an average score on both its financial health and profitability. RIGL is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make RIGL suitable for growth investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 10.66% | ||
ROE | 531.78% | ||
ROIC | 18.98% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 13.49% | ||
PM (TTM) | 9.75% | ||
GM | 89.6% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 15.94 | ||
Debt/FCF | 1.92 | ||
Altman-Z | -8.46 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.13 | ||
Quick Ratio | 2.04 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 19.91 | ||
Fwd PE | 17.66 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 10.77 | ||
EV/EBITDA | 11.78 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
18.72
-0.84 (-4.29%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 19.91 | ||
Fwd PE | 17.66 | ||
P/S | 1.87 | ||
P/FCF | 10.77 | ||
P/OCF | 10.63 | ||
P/B | 101.74 | ||
P/tB | N/A | ||
EV/EBITDA | 11.78 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 10.66% | ||
ROE | 531.78% | ||
ROCE | 24.03% | ||
ROIC | 18.98% | ||
ROICexc | 81.83% | ||
ROICexgc | N/A | ||
OM | 13.49% | ||
PM (TTM) | 9.75% | ||
GM | 89.6% | ||
FCFM | 17.33% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 15.94 | ||
Debt/FCF | 1.92 | ||
Debt/EBITDA | 1.98 | ||
Cap/Depr | 17.77% | ||
Cap/Sales | 0.22% | ||
Interest Coverage | 3.44 | ||
Cash Conversion | 119.12% | ||
Profit Quality | 177.72% | ||
Current Ratio | 2.13 | ||
Quick Ratio | 2.04 | ||
Altman-Z | -8.46 |